SCOTTSDALE, AZ / ACCESSWIRE / June 3, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is proud to announce that they have appointed Matthew McGee to serve as Chief Marketing Officer of the Company.
“I am over the top excited to assume the role of Chief Marketing Officer of CBD Life Sciences Inc,” Mr. McGee said. “I look forward to growing the current success that CBD Life Sciences has achieved. I couldn’t be anymore thankful for this wonderful opportunity, and I look forward to grow the company further, expand sales and bring in more revenue along with more customers as I have already started developing an amazingly effective strategic plan to make this all happen!”
“I am very pleased to welcome Matthew as the new CMO of CBD Life Sciences Inc,” President & CEO Lisa Nelson said. “Given his great experience in the Cannabis field and significant knowledge of Cannabidiol, I am confident that he will be an effective leader of the company.”
Mr. McGee is a passionate and compassionate leader of high performing teams with deep expertise in designing effective customer marketing strategies and building commercial capabilities that drive performance. Mr. McGee is also very knowledgeable in the computer world and currently holds an Associate’s Degree in Cyber Security from Westmoreland County Community college located in Pennsylvania. After completing that program, Mr. McGee decided the cannabis industry was a large sector and attended CSU-Pueblo for Cannabis Biology & Chemistry and obtained a Bachelors of Science.
The number of benefits CBD has is tremendous! These benefits include help with behavioral/neurological complications such as ADD/ADHD, anxiety, bipolar, OCD, PTSD, epilepsy, Parkinson’s, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn’s, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
LBC BIOSCIENCE’S Online Emporium
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings – all at very reasonable prices. Check out LBC Bioscience Inc’s newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
- Large Selection of Products (over 50 items and growing)
- 100% USA Made Products “organic & kosher.”
- All Products are THC-FREE (they contain 0.00% THC)
- Weekly Deals (new deals every week)
- 20% off on all products using code “LBC20.”
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc’s Main Website at www.lbcbioscienceinc.com
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC’s products can be viewed and purchased on the Company’s website at www.lbcbioscienceinc.com.
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc’s, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE:CBD Life Sciences Inc.
View source version on accesswire.com: